Tural, D. Et Al. 2021. Atezolizumab in Patients with Metastatic Urothelial Carcinoma Who Have Progressed After First-line Chemotherapy: Results of Real-life Experiences. European Urology Focus , vol.7, no.5 , 1061-1066.

Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... ÇAKAR, B.(2021). Atezolizumab in Patients with Metastatic Urothelial Carcinoma Who Have Progressed After First-line Chemotherapy: Results of Real-life Experiences. European Urology Focus , vol.7, no.5, 1061-1066.

Tural, Deniz Et Al. "Atezolizumab in Patients with Metastatic Urothelial Carcinoma Who Have Progressed After First-line Chemotherapy: Results of Real-life Experiences," European Urology Focus , vol.7, no.5, 1061-1066, 2021

Tural, Deniz Et Al. "Atezolizumab in Patients with Metastatic Urothelial Carcinoma Who Have Progressed After First-line Chemotherapy: Results of Real-life Experiences." European Urology Focus , vol.7, no.5, pp.1061-1066, 2021

Tural, D. Et Al. (2021) . "Atezolizumab in Patients with Metastatic Urothelial Carcinoma Who Have Progressed After First-line Chemotherapy: Results of Real-life Experiences." European Urology Focus , vol.7, no.5, pp.1061-1066.

@article{article, author={Deniz Tural Et Al. }, title={Atezolizumab in Patients with Metastatic Urothelial Carcinoma Who Have Progressed After First-line Chemotherapy: Results of Real-life Experiences}, journal={European Urology Focus}, year=2021, pages={1061-1066} }